<DOC>
	<DOCNO>NCT00110500</DOCNO>
	<brief_summary>The purpose study evaluate clinical laboratory safety SB-509 give single treatment intramuscular injection subject diabetic neuropathy .</brief_summary>
	<brief_title>Clinical Trial SB-509-0401 Subjects With Diabetic Neuropathy</brief_title>
	<detailed_description>Primary objective : To evaluate clinical laboratory safety SB-509 give single treatment intramuscular injection . To determine maximum tolerate dose ( MTD ) single treatment intramuscular injection SB-509 . Secondary objective : To evaluate low extremity clinical effect SB-509 treatment low limb diabetic neuropathy symptom , neurological examination , low extremity electrophysiological testing .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Have clinical diagnosis Diabetes Mellitus Type I II least 12 month prior study . Have receive diagnosis mild moderate sensorimotor diabetic neuropathy neurologist ( doctor specialize disorder nervous system ) endocrinologist ( doctor specialize diabetes ) . This type neuropathy loss sensation muscle function occur legs hand stock glove distribution . Subjects diabetic neuropathy result loss sensation muscle function one nerve result loss nerve function blood vessel cause low blood pressure , eligible . Be adult male female age 18 65 . Be able willing read sign consent form . Be willing participate study outpatient make require visit study center treatment treatment period Meet follow study requirement . Have abnormal sign sensorimotor diabetic neuropathy base rating scale base question physical exam call Neuropathy Impairment ScoreLower Limb ( NISLL ) clinical scoring system . Have abnormal result specialize nerve test leg . The study doctor study staff specialize nerve test Nerve Conduction Test Quantitative Sensory Testing , read . Have measurable sural nerve response leg Have HgbA1C level 10 % low , stable blood sugar control least 3 month . The study doctor check . Have eye exam eye doctor rule presence abnormal growth blood vessel proliferative diabetic retinopathy ( eye complication diabetes ) . Have normal , complete blood count . The study doctor check . Have normal urine test . If female , : ( ) postmenopausal ( b ) surgically sterile ( c ) use two form birth control negative pregnancy test within 3 day receive study drug . If male able make female pregnant , use accept form birth control . Have uptodate screening test cancer recommend American Cancer Society . These test include PSA blood test prostate cancer ( male age 45 ) , pap smear cervical cancer ( female ) , mammogram ( female age 40 ) , flexible sigmoidoscopy colon cancer ( age 50 ) . To study , must write proof normal test result within last 12 month . If screening test show cancer , able study . Have normal chest Xray without evidence heart enlargement congestive heart failure . Subjects follow NOT eligible participate study : Have moderate severe ischemic heart disease , history congestive heart failure myocardial infarction ( heart attack ) within previous 6 month . Have chronic foot leg ulcer &gt; 1 month , gangrene low extremity , previous amputation lower extremity . Have symptoms intermittent claudication ( leg pain exercise associate peripheral artery disease ) and/or ankle brachial index ( calculation difference arm leg blood pressure ) less &lt; 0.75 . Have history cancer within past 10 year ( except curable nonmelanoma cancer skin , superficial bladder cancer complete remission , cancer complete remission least 5 year ) . Be pregnant , breastfeeding , man woman reproductive potential ( able make baby ) use accepted form birth control . Expect require surgery within 4 week receive study drug . Have condition increase risk bleed ( example , hemophilia similar disorder ) require treatment warfarin , clopidogrel , aspirin ( least 325 mg day ) within 2 week receive study drug within 24 hour afterwards . Have stroke bleed brain within last 12 month . Have bleed gastrointestinal tract ( esophagus , stomach , duodenum , intestine , rectum ) within last 12 month . If ever bleed large intestine rectum , need negative colonoscopy episode within last 3 year . Have condition , opinion study doctor , might cause problem study ( example , affect health study test result ) . Be participate another research study study within 30 day receive study drug . Have colon polyp . If history benign colonic polyp remove , must evidence normal colonoscopy within last 12 month . Have inflammatory disorder blood vessel ( inflammatory angiopathy , Buerger 's disease ) . Have active infection require antibiotic take swallow administer directly vein . If infection past , must receive treatment infection within 2 week receive study drug . Have abnormal kidney function . Require drug depresses immune system ( methotrexate , cyclophosphamide , cyclosporine ) receive study drug 30 day afterwards . Have know disorder affect immune system ( HIV/AIDS , HBV , HCV , sarcoidosis , tuberculosis , rheumatoid arthritis , autoimmune disorder ) . Be use oral , injectable , intravenous ( directly vein ) corticosteroid ( prednisone ) within 30 day start study . Have history drug addiction ( include smoking ) within 12 month start study . Have psychiatric ( mental ) addictive disorder would prevent subject able read sign consent form . Have neuropathy extremity cause condition diabetes ( example , alcohol abuse liver renal disease ) . Have receive gene transfer agent within last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Neuropathy</keyword>
</DOC>